A San Antonio-based venture capital firm that specializes in medical devices said Tuesday that it closed its final round of fundraising after securing about $12 million in commitments from more than 40 investors. The Targeted Technology Fund I … The most recent investment was announced Tuesday when San Antonio-based drug company ViroXis said it would receive $500000 from the fund to help develop a plant-based topical drug to treat warts caused by human papillomavirus.
Read more:
S.A. venture capitalists close fund at $12 million